ClinicalTrials.Veeva

Menu

Robotic Rehabilitation of the Upper Limb After a Stroke (ROBOASSIST)

C

Clinique Les Trois Soleils

Status

Terminated

Conditions

Stroke

Treatments

Device: Robot InMotion 2.0
Other: Conventional rehabilitation

Study type

Interventional

Funder types

Other

Identifiers

NCT03584477
2011-A00632-39

Details and patient eligibility

About

Hemiparesis is the most common motor disorder after a stroke. Most patients do not recover functional use of their paretic upper limb.

The use of robotic assistance provides intensive motor training through a large number of repetitive movements, usually oriented and interactive tasks (pointing tasks, tracking paths tasks...). These feature have been demonstrated to be critical to stimulate brain plasticity after a brain damage. The InMotion Arm 2.0 manipulator works with an adaptive algorithm that provide patients with real-time Assistance-as-Needed™ desgned to enhance motor performance.

Hypothesis: In the sub-acute phase of stroke, the structured practice of a large number of repeated movements will increase motor function of the upper limb compared to conventional rehabilitation. Secondly, this practice will be more effective in a free active mode (without assistance) than an active assisted mode (Assistance-as-Needed™).

Expected secondary benefits: Subjective impression of improved use of the upper limb in activities of daily living and reduction of spastic cocontractions affecting the agonist and antagonist muscles during movements of the upper limb.

Objectives: This randomized controlled trial will evaluate the effects of structured repetition programs of arm movements, on the function of the hemiparetic upper limb and motor control, between 4 and 10 weeks after the stroke, using a robotic device with or without assistance in partial substitution of conventional rehabilitation care, compared to a program with conventional care alone.

Enrollment

54 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥18 years;
  • Stroke hemiparesis on unilateral focal lesion dating from 4 to 10 weeks at baseline;
  • Active flexion of the paretic shoulder ≥15 °;
  • Average score on the modified scale of Frenchay <5;
  • Patient having agreed to sign an informed consent.

Exclusion criteria

  • Passive extension of the paretic elbow <120 °;
  • Passive extension of the paretic wrist <10 °;
  • Cognitive dysfunction or progressive intercurrent illness making effective communication or participation in the study impossible;
  • Infection, inflammation or complex regional pain syndrome of the paretic upper extremity;
  • Injection of botulinum toxin to the upper limb less than 3 months old;
  • Patient under safeguard of justice;
  • Patient include in an other clinical trial.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

54 participants in 3 patient groups

Conventional rehabilitation
Active Comparator group
Description:
5 sessions / week of 1 hour of occupational therapy
Treatment:
Other: Conventional rehabilitation
Robotic rehabilitation with assistance
Active Comparator group
Description:
5 sessions / week of 1 hour of rehabilitation of the upper limb with 30 min of conventional rehabilitation and 30 min of robotic rehabilitation with assistance.
Treatment:
Device: Robot InMotion 2.0
Other: Conventional rehabilitation
Non-assistance robotic rehabilitation
Active Comparator group
Description:
5 sessions / week of 1 hour of rehabilitation of the upper limb including 30 min of conventional rehabilitation and 30 min of robotic rehabilitation without assistance.
Treatment:
Device: Robot InMotion 2.0
Other: Conventional rehabilitation

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems